Patients are online, and they are talking about clinical trials. Social media interactions are allowing patients to make more informed choices about clinical trials, but the flow of information also has the potential to sway trial results when patients share study details. According to Craig Lipset of Pfizer, “It’s only a matter of time before Facebook jeopardizes the scientific integrity of a study.” (